NAS receives non-compliance notice from Nasdaq

TriMed Staff | | Health Imaging | Diagnostic Imaging

Nasdaq has indicated that North American Scientific (NAS) has failed to regain compliance with the minimum $1 bid price per share requirement within the 180 calendar-day compliance period, which ended on April 2.

Nasdaq also noted that the Chatsworth, Calif.-based NAS is not eligible for an additional 180 calendar-day compliance period given that it does not meet the Nasdaq capital market initial inclusion criteria of $15 million market value of publicly held shares.

Therefore, the company's common stock is subject to delisting from the Nasdaq capital market at the opening of business on April 15. 

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.